Capricor Therapeutics | CAPR - Net Income


Capricor Therapeutics reported $-24.39M in Net Income for its fiscal quarter ending in March of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -5.77M 2.26M Jun/2023
Bioline Rx USD -977K 2.96M Sep/2025
Capricor Therapeutics USD -24.39M 17.27M Mar/2025
Cipla INR 6.76B 6.75B Dec/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Geron USD -31.14M 12.72M Dec/2025
Grifols EUR 148.4M 15.76M Sep/2025
Immunic USD -24.37M 2.99M Sep/2024
J&J USD 5.12B 36M Dec/2025
Prothena USD -36.54M 89.23M Sep/2025
PTC Therapeutics USD -134.96M 150.86M Dec/2025
Sarepta Therapeutics USD -412.23M 232.28M Dec/2025